These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26788993)

  • 1. The role of small adaptor proteins in the control of oncogenic signalingr driven by tyrosine kinases in human cancer.
    Naudin C; Chevalier C; Roche S
    Oncotarget; 2016 Mar; 7(10):11033-55. PubMed ID: 26788993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of Tyrosine Kinase Signalling by Small Adaptors in Colorectal Cancer.
    Mevizou R; Sirvent A; Roche S
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31091767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional diversity of adaptor proteins involved in tyrosine kinase signalling.
    Csiszár A
    Bioessays; 2006 May; 28(5):465-79. PubMed ID: 16615089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.
    Goel RK; Lukong KE
    Cancer Metastasis Rev; 2016 Jun; 35(2):179-99. PubMed ID: 27067725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of oncogenic signaling induced by tyrosine kinases in tumors by SILAC-based quantitative proteomic approach].
    Sirvent A; Urbach S; Roche S
    Med Sci (Paris); 2014 May; 30(5):558-66. PubMed ID: 24939544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cbl family proteins: ring leaders in regulation of cell signaling.
    Swaminathan G; Tsygankov AY
    J Cell Physiol; 2006 Oct; 209(1):21-43. PubMed ID: 16741904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoplastic transformation by the gep oncogene, Galpha12, involves signaling by STAT3.
    Kumar RN; Shore SK; Dhanasekaran N
    Oncogene; 2006 Feb; 25(6):899-906. PubMed ID: 16247467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A historical overview of protein kinases and their targeted small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.
    Saucier C; Papavasiliou V; Palazzo A; Naujokas MA; Kremer R; Park M
    Oncogene; 2002 Mar; 21(12):1800-11. PubMed ID: 11896612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic kinase signalling.
    Blume-Jensen P; Hunter T
    Nature; 2001 May; 411(6835):355-65. PubMed ID: 11357143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.
    Mahajan NP; Whang YE; Mohler JL; Earp HS
    Cancer Res; 2005 Nov; 65(22):10514-23. PubMed ID: 16288044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the NF-kappaB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKalpha.
    Malinge S; Monni R; Bernard O; Penard-Lacronique V
    Oncogene; 2006 Jun; 25(25):3589-97. PubMed ID: 16434962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
    Marshall M
    Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ups and downs of SRC regulation: tumor suppression by Cbp.
    Resh MD
    Cancer Cell; 2008 Jun; 13(6):469-71. PubMed ID: 18538730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring signal transduction in cancer: tyrosine kinase gene expression profiling.
    Weier HU; Zitzelsberger HF; Hsieh HB; Sun MV; Wong M; Lersch RA; Yaswen P; Smida J; Kuschnick C; Clark OH
    J Histochem Cytochem; 2001 May; 49(5):673-4. PubMed ID: 11304810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A switch from p130Cas/Crk to Gab1/Crk signaling correlates with anchorage independent growth and JNK activation in cells transformed by the Met receptor oncoprotein.
    Lamorte L; Kamikura DM; Park M
    Oncogene; 2000 Dec; 19(52):5973-81. PubMed ID: 11146548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis of high-throughput RNAi screen data identifies the FER and CRKL tyrosine kinases as new regulators of the mitogenic ERK-dependent pathways in transformed cells.
    Nizard P; Ezan F; Bonnier D; Le Meur N; Langouët S; Baffet G; Arlot-Bonnemains Y; Théret N
    BMC Genomics; 2014 Dec; 15(1):1169. PubMed ID: 25540073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKC-regulated myogenesis is associated with increased tyrosine phosphorylation of FAK, Cas, and paxillin, formation of Cas-CRK complex, and JNK activation.
    Goel HL; Dey CS
    Differentiation; 2002 Aug; 70(6):257-71. PubMed ID: 12190987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
    Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
    Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.